NewGenIvf Group Limited Announces Reverse Stock Split

NewGenIvf Group Limited announced a reverse stock split of its issued and unissued shares at an exchange ratio of one (1) share for every four (4) shares. This action, approved by the Board of Directors on September 16, 2026, does not require shareholder approval. The reverse stock split will become effective on October 12, 2026, with Class A Ordinary Shares commencing trading on a split-adjusted basis on the Nasdaq Capital Market under the symbol "NIVF" and a new CUSIP number G0544E600. The split is expected to reduce the number of outstanding Class A Ordinary Shares from approximately 35,688,329 to 8,922,083. Fractional shares will not be issued; instead, shareholders entitled to fractional shares will receive one full post-reverse stock split share. All outstanding options, warrants, and convertible securities will also be adjusted proportionally. The par value of the ordinary shares remains unchanged, and the total number of authorized shares is unlimited.